Kim U, Bae J, Kim J, Kim J, Kim S, Han S
Cancers (Basel). 2024; 16(17).
PMID: 39272893
PMC: 11394477.
DOI: 10.3390/cancers16173036.
Leng Y, Wang X, Zheng T, Peng F, Xiong L, Wang Y
Sci Rep. 2024; 14(1):12456.
PMID: 38816463
PMC: 11139946.
DOI: 10.1038/s41598-024-63369-1.
Hong Y, Peng J, Zeng Y, Deng X, Xu W, Wang J
Clin Transl Oncol. 2024; 26(12):3013-3019.
PMID: 38780807
DOI: 10.1007/s12094-024-03499-0.
Li A, Bloomgarden N, Friedman S, Flusberg M, Chernyak V, Berkenblit R
Abdom Radiol (NY). 2024; 49(6):2074-2082.
PMID: 38499827
PMC: 11213803.
DOI: 10.1007/s00261-024-04189-9.
Leng Y, Kan A, Wang X, Li X, Xiao X, Wang Y
BMC Cancer. 2024; 24(1):307.
PMID: 38448945
PMC: 10916071.
DOI: 10.1186/s12885-024-12037-8.
Application of medical imaging in ovarian cancer: a bibliometric analysis from 2000 to 2022.
Leng Y, Li S, Zhu J, Wang X, Luo F, Wang Y
Front Oncol. 2023; 13:1326297.
PMID: 38111527
PMC: 10725957.
DOI: 10.3389/fonc.2023.1326297.
Gynecologic oncology tumor board: the central role of the radiologist.
Recht H, Shampain K, Flory M, Nougaret S, Barber E, Jha P
Abdom Radiol (NY). 2023; 48(10):3265-3279.
PMID: 37386301
DOI: 10.1007/s00261-023-03978-y.
Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers.
Bae G, Berezhnoy G, Koch A, Cannet C, Schafer H, Kommoss S
Front Mol Biosci. 2023; 10:1158330.
PMID: 37168255
PMC: 10166069.
DOI: 10.3389/fmolb.2023.1158330.
Machine learning combined with radiomics and deep learning features extracted from CT images: a novel AI model to distinguish benign from malignant ovarian tumors.
Jan Y, Tsai P, Huang W, Chou L, Huang S, Wang J
Insights Imaging. 2023; 14(1):68.
PMID: 37093321
PMC: 10126170.
DOI: 10.1186/s13244-023-01412-x.
Rapid MRI Abdomen for Assessment of Clinically Suspected Acute Appendicitis in the General Adult Population: a Systematic Review.
Kim D, Woodham B, Chen K, Kuganathan V, Edye M
J Gastrointest Surg. 2023; 27(7):1473-1485.
PMID: 37081221
PMC: 10366263.
DOI: 10.1007/s11605-023-05626-8.
Ovarian Fibroma Presents As Uterine Leiomyoma in a 61-Year-Old Female: A Case Study.
Borukh E, Ilyaev B, Muminiy S, Babayev M, Musheyev Y, Levada M
Cureus. 2023; 15(3):e36264.
PMID: 37073210
PMC: 10105824.
DOI: 10.7759/cureus.36264.
Imaging ovarian cancer - from baseline characteristics to high-risk image factors.
Sartor H, Bjurberg M, Asp M, Kahn A, Brandstedt J, Kannisto P
J Ovarian Res. 2023; 16(1):78.
PMID: 37069618
PMC: 10108495.
DOI: 10.1186/s13048-023-01154-w.
Clinical Significance of the Combination of Serum HE4 Levels, Hemoglobin-to-Red Cell Distribution Width Ratio, and CT Imaging for the Pretreatment Assessment of Adnexal Masses.
Jang T, Kim H, Eo W, Kim K, Lee C, Kim M
J Cancer. 2023; 14(4):600-610.
PMID: 37057288
PMC: 10088533.
DOI: 10.7150/jca.81174.
A nomogram model based on clinical markers for predicting malignancy of ovarian tumors.
Gao B, Zhao X, Gu P, Sun D, Liu X, Li W
Front Endocrinol (Lausanne). 2022; 13:963559.
PMID: 36506042
PMC: 9729545.
DOI: 10.3389/fendo.2022.963559.
Recent Imaging Updates and Advances in Gynecologic Malignancies.
Daoud T, Sardana S, Stanietzky N, Klekers A, Bhosale P, Morani A
Cancers (Basel). 2022; 14(22).
PMID: 36428624
PMC: 9688526.
DOI: 10.3390/cancers14225528.
Imaging of pediatric ovarian tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
Behr G, Morani A, Artunduaga M, Desoky S, Epelman M, Friedman J
Pediatr Blood Cancer. 2022; 70 Suppl 4:e29995.
PMID: 36184758
PMC: 10642215.
DOI: 10.1002/pbc.29995.
Delayed presentation of a huge abdominopelvic mass during the COVID-19 pandemic.
Gurung R, Azna Ali A, Hayati F, Rajakumar V, Payus A, Wynn A
Ann Med Surg (Lond). 2022; 82:104576.
PMID: 36117529
PMC: 9465489.
DOI: 10.1016/j.amsu.2022.104576.
Management of the Adnexal Mass: Considerations for the Family Medicine Physician.
Bullock B, Larkin L, Turker L, Stampler K
Front Med (Lausanne). 2022; 9:913549.
PMID: 35865172
PMC: 9294310.
DOI: 10.3389/fmed.2022.913549.
Evaluation of a CD13 and Integrin αβ Dual-Receptor Targeted Tracer Ga-NGR-RGD for Ovarian Tumor Imaging: Comparison With F-FDG.
Long Y, Shao F, Ji H, Song X, Lv X, Xia X
Front Oncol. 2022; 12:884554.
PMID: 35664759
PMC: 9158524.
DOI: 10.3389/fonc.2022.884554.
Mimics and Pitfalls of Primary Ovarian Malignancy Imaging.
Elsherif S, Agely A, Gopireddy D, Ganeshan D, Hew K, Sharma S
Tomography. 2022; 8(1):100-119.
PMID: 35076619
PMC: 8788482.
DOI: 10.3390/tomography8010009.